Adaptable AI system detects subtle changes in imaging, has potential across multiple clinical settings

A versatile new artificial intelligence system can predict outcomes for a variety of pathologies based on assessments of longitudinal imaging datasets. 

The Learning-based Inference of Longitudinal imAge Changes, or LILAC, system harnesses machine learning to review medical images that have been collected over a prolonged period. LILAC was designed to offer greater training flexibility.  

Unlike other AI models, it does not require extensive preprocessing or customization of data, as it can automatically detect subtle alterations and adjust accordingly—something developers typically must do manually. It does this by ignoring irrelevant image aspects and instead highlights the time-sensitive details of interest. 

“This new tool will allow us to detect and quantify clinically relevant changes over time in ways that weren't possible before, and its flexibility means that it can be applied off the shelf to virtually any longitudinal imaging dataset,” explained study senior author Mert Sabuncu, PhD, vice chair of research and a professor of electrical engineering in radiology at Weill Cornell Medicine. “This enables LILAC to be useful not just across different imaging contexts but also in situations where you aren’t sure what kind of change to expect.” 

The tool can be used in a variety of settings, including on images from pathology and radiology. It has been tested in multiple proof-of-concept studies ranging from imaging of tissue samples and pathology slides to MRI of the brain. 

In the MRI assessment, LILAC was tasked with determining how much time had passed between multiple series of brain scans a group of older adults had undergone. Researchers also tested its ability to predict cognitive scores based on images from a group of adults with mild cognitive impairment. In both cases, LILAC outperformed standard methods of evaluation by 40%. In this sense, it could be used to predict who may be susceptible to cognitive decline. 

It also was tested on microscope images showing in-vitro-fertilized embryos as they develop, in addition to a group of images from new embryos. For this analysis, LILAC was prompted to determine which images had been taken earlier. And in a similar experiment, it was presented with images of a wound taken over time and tasked with placing them in chronological order based on signs of healing. In both tests, LILAC achieved 99% accuracy. 

As the reliability of AI often comes into question, the team took their work a step further by training LILAC to highlight the imaging features that were most relevant to its predictions. This enhances its applicability to a wide range of clinical uses, the group suggested. 

“LILAC provides a streamlined approach that allows for easy adaptation to various types of longitudinal image datasets, minimizing the complexity and customization often associated with other methods,” they noted. “This flexibility makes LILAC accessible to a wide range of applications, while its simplicity ensures that it can be implemented without the need for extensive customization.” 

Learn more about the findings here. 

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She began covering the medical imaging industry for Innovate Healthcare in 2021.

Around the web

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?